Spreadsheet: ec817706-5e9a-49b5-9f26-e0c56e11b282
Sheet: Sheet1

Test Referenced | Entry Type | Mayo ID | Description | Reporting Description | Method | Collection Container | Temperature | Stability | [NAME] | Unit of Measure | [NAME] | Minimum Volume | Reject Due To | Reference Values | Days/Times Performed | Analytic Time | Maximum Lab Time | CPT Units | CPT Code | LOINC® Code | LOINC® Attributes | Always Performed | Orderable Separately | Performing Location
CDG | Test | CDG | Carbohydrate Deficient Transferrin for Congenital Disorders of Glycosylation, Serum | CDG, S | Affinity Chromatography-Mass Spectrometry (MS) | Plastic vial: PlV |  |  | 0.1 | mL | Collection Container/Tube:  Preferred: Red top Acceptable: Serum gel Submission Container/Tube: Plastic vial [NAME]: 0.1 mL  Additional Information:  1. Patient's age is required. 2. Reason for referral is required. 3. This test is for congenital disorders of glycosylation. If the ordering physician is looking for evaluation of alcohol abuse, order CDTA / Carbohydrate Deficient Transferrin, [NAME], Serum. Forms: 1. New York Clients-Informed consent is required. Please document on the request form or electronic order that a copy is on file. An Informed Consent for Genetic Testing (Supply T576) is available in Special Instructions.  2. If not ordering electronically, submit a Biochemical Genetics Request Form (Supply T439) with the specimen. | 0.05 mL | Hemolysis	Mild OK; Gross Reject Thawing	Warm <7 days OK; Cold OK Lipemia	Mild OK; [NAME] OK Icterus	Mild OK; [NAME] OK Other	NA | Ratio	Normal	Indeterminate	Abnormal Transferrin Mono-oligo/Di-oligo [NAME]	< or =0.06	0.07-0.09	> or =0.10 Transferrin A-oligo/Di-oligo [NAME]	< or =0.011	0.012-0.021	> or =0.022 Transferrin Tri-sialo/Di-oligo [NAME]	< or =0.05	0.06-0.12	> or =0.13 Apo CIII-1/Apo CIII-2 Ratio	< or =2.91	2.92-3.68	> or =3.69 [NAME]	< or =0.48	0.49-0.68	> or =0.69 | Monday,Thursday; 8 a.m. | 5 days (Not reported Saturday or Sunday) | 10 days | 1 | 82373 |  |  |  |  | Rochester
CDG | [NAME] | SERUM | Serum |  |  |  | Frozen | 45 days
CDG | Order Question | BG160 | Reason for Referral |  | Answer List
CDG | Option | BG160-1 | Congenital disorders of glycosylation
CDG | Option | BG160-2 | Follow-up of known patient with CDG
CDG | Option | BG160-3 | Evaluation of alcohol abuse - change test to 82425 (CDTA) [NAME], Adult, S
CDG | Result | BG160 | Reason for Referral | Reason for Referral | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 42349-1 | Reason for referral:Find:Pt:^Patient:Nar:
CDG | Result | 31721 | Mono-oligo/Di-oligo [NAME] | Mono-oligo/Di-oligo [NAME] | Numeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 35469-6 | Mono-oligosaccharide/Di-oligosaccharide:MRto:Pt:Ser/Plas:Qn:
CDG | Result | 31720 | A-oligo/Di-oligo [NAME] | A-oligo/Di-oligo [NAME] | Numeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 35475-3 | A-oligosaccharide/Di-oligosaccharide:MRto:Pt:Ser/Plas:Qn:
CDG | Result | 34474 | Tri-sialo/Di-oligo [NAME] | Tri-sialo/Di-oligo [NAME] | Numeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
CDG | Result | 34476 | Apo CIII-1/Apo CIII-2 Ratio | Apo CIII-1/Apo CIII-2 Ratio | Numeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
CDG | Result | 34475 | [NAME] | [NAME] | Numeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | In Process
CDG | Result | 50820 | Interpretation | Interpretation | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 59462-2
CDG | Result | 50822 | Reviewed By | Reviewed By | Numeric